Betta Pharmaceuticals Catalyst Calendar
Proactively evaluate Betta Pharmaceuticals Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Betta Pharmaceuticals Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 01 Aug 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 01 Aug 2020 | Phase I Trial Initiation | Betta Pharmaceuticals Co Ltd; Shanghai Shale Technology Co Ltd | 300558 | befortinib mesylate | Oncology | Non-Small Cell Lung Cancer | Clinical Trial Registry |
| 01 Mar 2020 | Phase II Trial Completion | Betta Pharmaceuticals Co Ltd | 300558 | ensartinib hydrochloride | Oncology | Lung Cancer; Non-Small Cell Lung Cancer | Clinical Trial Registry |
| 01 Feb 2020 | Phase II/III Trial Initiation | Betta Pharmaceuticals Co Ltd; InventisBio Co Ltd | 300558; 688382 | befortinib mesylate | Oncology | Lung Adenocarcinoma; Non-Small Cell Lung Cancer | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer